(Reuters) -U.S. drug distributor McKesson raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, banking on robust demand for specialty medicines. High profit margins for specialty medicines, which treat complex conditions such as rheumatoid arthritis and cancer, have encouraged companies to expand in the market. Texas-headquartered Mckesson expects per-share profit in the range of $37.10 to...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Overview * Veracyte ( VCYT ) Q2 revenue rises 14% yr/yr to $130.2 mln, beating expectations * Adjusted EBITDA for Q2 improves 49% to $35.8 mln * Co raises full-year 2025 testing revenue guidance Outlook * Veracyte ( VCYT ) raises 2025 testing revenue guidance to $477 mln to $483 mln * Company expects 2025 testing revenue growth of 14%...

Overview * Inotiv ( NOTV ) Q3 fiscal 2025 revenue rises 23.5% to $130.7 mln, beating expectations, per LSEG data * Adjusted EBITDA for Q3 fiscal 2025 beats estimates, reaching $11.6 mln * Company reports Q3 fiscal 2025 net loss of $17.6 mln Result Drivers * RMS GROWTH - Revenue from Research Models & Services rose 34.1%, driven by increased...